Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Yoshiyama, Takashi ; Saito, Yasuki ; Masuda, Kunitsugu ; Nakanishi, Yoshiko ; Kido, Yasutoshi ; Uchimura, Kazuhiro ; Mitarai, Satoshi ; Suzuki, Tadaki ; Nakagama, Yu ; Kubota, Hiroshi ; Satomi, Maki ; Uchikoba, Sana ; Ohnishi, Makoto ; Wakita, Takaji ; Kato, Seiya ; Kato, Katsunobu
• Description:
  We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.
• Subjects:
  Adult Aged Antibodies, Viral Coronavirus Infections COVID-19 Serological Testing Female Humans Male Middle Aged Prevalence Seroepidemiologic Studies Young Adult

  More +
• Source:
  Emerg Infect Dis. 27(2):628-631
• Pubmed ID:
  33496235
• Pubmed Central ID:
  PMC7853542
• Document Type:
  Journal Article
• Place as Subject:
  Japan
• Location:
  Asia
• Volume:
  27
• Issue:
  2
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:77374fba84776a98466012195945cc38576a4a47256f0666a0e8b3425514a0c7
• Download URL:
  https://stacks.cdc.gov/view/cdc/102481/cdc_102481_DS1.pdf
• File Type:
  [PDF - 431.59 KB ]